Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

July IP Litigation Newsletter

The Cloakroom with Peter Roskam

The Cloakroom with Peter Roskam: 2024 Republican National Convention

Elise Elam Moderates Panel at ACLI Compliance and Legal Sections Annual Meeting

James Sherer Speaks on Panel at The Masters Conference

On June 22, Senator Thom Tillis (R – NC) and Senator Chris Coons (D – DE) introduced the Patent Eligibility Restoration Act of 2023, which seeks to eliminate all judicial exceptions to patent eligibility.<a href="#_ftn1" id="_ftnref1">[1]</a> The bill proposes that “[a]ny invention or discovery that can be claimed as a useful process, machine, manufacture, or composition of matter, or any useful improvement thereof” should be eligible for patent protection, with the following exceptions:
<ul>
 	<li>A mathematical formula that is not part of an invention that is in a category described in subparagraph (B).</li>
 	<li>A mental process performed solely in the mind of a human being.</li>
 	<li>An unmodified human gene, as that gene exists in the human body.</li>
 	<li>An unmodified natural material, as that material exists in nature.</li>
 	<li>A process that is substantially economic, financial, business, social, cultural, or artistic.</li>
</ul>
Regarding unmodified human genes and natural materials, the bill states that “[a] human gene or natural material shall not be considered to be unmodified if the gene or material, as applicable, is ‘(A) isolated, purified, enriched, or otherwise altered by human activity’ or ‘(B) otherwise employed in a useful invention or discovery.’” According to the bill, eligibility should be determined without regard to, among other things, the manner in which the invention was made or whether a claim element is known, conventional, routine, or naturally occurring.

The introduction of the bill comes just weeks after the Supreme Court requested that the respondents respond to CareDx’s petition for writ of certiorari in the <a href="https://www.ipintelligencereport.com/2023/06/01/will-the-supreme-court-reevaluate-the-subject-matter-eligibility-of-diagnostic-claims/"><em>CareDx, Inc. v. Natera, Inc.</em></a> case. This bill is welcome news for those seeking clarity on what is and what isn’t patent-eligible subject matter.

<hr class="wp-block-separator has-alpha-channel-opacity">

<a href="#_ftnref1" id="_ftn1">[1]</a> https://www.tillis.senate.gov/services/files/4B41CBF2-57AB-4E8E-9E93-7D714A7AAB40

Congress Seeks to Eliminate the Judicial Exceptions to Patent Eligibility

Featured Insights

Related Services

Featured Insights